Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra
Pio Conti, F. Pregliasco, Rosa Grazia Bellomo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8076-8076
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 113
Challenges and Future Trends in the Treatment of Psoriasis
Hyun Ji Lee, Miri Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13313-13313
Open Access | Times Cited: 106
Therapeutic potential of targeting interleukin‐1 family cytokines in chronic inflammatory skin diseases*
Laura Calabrese, Zeno Fiocco, Takashi Satoh, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 6, pp. 925-941
Open Access | Times Cited: 44
The IL-1 cytokine family as custodians of barrier immunity
Laura Matarazzo, Yasmina Hernandez-Santana, Patrick Walsh, et al.
Cytokine (2022) Vol. 154, pp. 155890-155890
Open Access | Times Cited: 44
IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications
Helena Iznardo, L. Puig
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9479-9479
Open Access | Times Cited: 43
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers
Anna Sobiepanek, Łukasz Kuryk, Mariangela Garofalo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2249-2249
Open Access | Times Cited: 39
Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
Karolina Makowska, Joanna Nowaczyk, Leszek Blicharz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 781-781
Open Access | Times Cited: 35
Activation of Mast Cells by Neuropeptides: The Role of Pro-Inflammatory and Anti-Inflammatory Cytokines
D Lauritano, F Mastrangelo, Cristian D’Ovidio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4811-4811
Open Access | Times Cited: 30
Current developments and perspectives in psoriasis
Michael P. Schön, Dagmar Wilsmann‐Theis
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 363-372
Open Access | Times Cited: 25
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Lisha Li, Jiaye Lu, Jun Liu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 15
Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma - Smilax glabra Roxb herb pair for the treatment of psoriasis
XueQing Hu, Cong Qi, Fang Feng, et al.
Phytomedicine (2022) Vol. 105, pp. 154384-154384
Closed Access | Times Cited: 31
Mast Cells and Interleukins
Antonio Giovanni Solimando, Vanessa Desantis, Doménico Ribatti
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14004-14004
Open Access | Times Cited: 29
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Chongshan Yuan, Yuhong He, Kunyu Xie, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 20
The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis
Kajetan Kiełbowski, Wiktoria Stańska, Estera Bakinowska, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3640-3675
Open Access | Times Cited: 6
Further Understanding of Neuro-Immune Interactions in Allergy: Implications in Pathophysiology and Role in Disease Progression
George Ν. Konstantinou, Gerasimos Konstantinou, Christopher Koulias, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 1273-1291
Open Access | Times Cited: 24
Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14633-14633
Open Access | Times Cited: 13
The potency of common proinflammatory cytokines measurement for revealing the risk and severity of anxiety and depression in psoriasis patients
Nannan Tong, Yu Zhang, An-ping Yang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 19
Phlorofucofuroeckol-A refined by edible brown algae Ecklonia cava indicates anti-inflammatory effects on TNF-α/IFN-γ-stimulated HaCaT keratinocytes and 12-O-tetradecanoylphorbol 13-acetate-induced ear edema in BALB/c mice
Kirinde Gedara Isuru Sandanuwan Kirindage, Arachchige Maheshika Kumari Jayasinghe, Eui-Jeong Han, et al.
Journal of Functional Foods (2023) Vol. 109, pp. 105786-105786
Open Access | Times Cited: 12
IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases
Francesco Borgia, Paolo Custurone, Federica Li Pomi, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 372-372
Open Access | Times Cited: 14
Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis
Laura Bonzano, Francesco Borgia, Rossella Casella, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1100-1100
Open Access | Times Cited: 8
Emerging functions and therapeutic targets of IL‐38 in central nervous system diseases
Yuan Gao, Luwei Cai, Yulu Wu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 2
Aktuelle Entwicklungen und Perspektiven bei Psoriasis
Michael P. Schön, Dagmar Wilsmann‐Theis
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 4, pp. 363-373
Open Access | Times Cited: 5
Potential Role of IL-37 in Atopic Dermatitis
Alicja Mesjasz, Magdalena Trzeciak, Jolanta Gleń, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2766-2766
Open Access | Times Cited: 5
Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
Abdolreza Esmaeilzadeh, Nazila Bahmaie, Elham Nouri, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12552-12552
Open Access | Times Cited: 11
Circ_0082476 targets miR-138-5p to promote proliferation, invasion, migration and inflammation in IL-22-treated human keratinocytes by upregulating BRD4
Jia-Jing Lu, Yu Wang, Jing Wang, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110095-110095
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top